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came the Faculty hospital of the 2nd Medical Faculty, Charles Uni-
versity, and the department of nuclear diagnostics joining togeth-
er with the therapeutic part of the Endocrinological Institute built,
the Clinic of Nuclear Medicine. In 1998 the Clinic moved to the
new faculty building (Fig. 1) and the equipment was modernised,
which meant the Clinic reached nation-wide status and accep-
tance.
The Clinic today
In 1999 dr Petr Vlcek (Fig. 2) became the head of the Clinic
and under his leadership the Clinic continues its diagnostic, ther-
apeutic, scientific and pedagogic work. Since 2001 the Clinic has
housed the Centre for thyroid oncology and endocrine orbitopa-
thy of the 2nd Faculty of Medicine, Charles University, which co-
vers the whole Czech Republic. All the equipment and procedures
fulfill the conditions given by the International Atomic Energy Agen-
cy (IAEA) and by the State Office of Nuclear Safety of the Czech
Republic. The Clinic has about 60 employees (14 of them medical
doctors, 3 physicists, 2 radiochemists).
Therapy
The therapeutic part of the Clinic is oriented to differentiated
follicular and papillary thyroid cancer. The database of the Clinic
contains over 6,500 patients, and 900 patients per year are treat-
ed (more than 90% of them with thyroid cancer). The first thera-
pies with 131I MIBG of medullary thyroid cancer were carried out in
1994, of neuroblastoma in 1997, in co-operation with the Clinic of
Children’s Oncology, and of carcinoid
(1999) and malignant pheochromocy-
toma in 2001. The department is
equipped with audio-visual monitoring,
which enables to be in permanent but
indirect contact with the patients treat-
ed with 131I.
Because the department has had
a continuous tradition of 131I treatment
for almost 50 years, there is a lot of data
for research. In co-operation with med-
ical physicists and radiation protection
officers much research on the biokinet-
ics of 131I has been carried out in order
to optimise the dosage [1–3].
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History of the Clinic
The Department of Nuclear Medicine of the Motol City Hospi-
tal was founded by professor Karel Šilink in 1959 as part of the
Institute of Endocrinology. The department, with 20 beds, was
designed for diagnosis and 131I therapy of thyrotoxicosis and thy-
roid cancer. In 1965 professor Jan Nemec became the head of
the department and the department was equipped with new scin-
tigraphs by Siemens and Picker, which improved the diagnostic
possibilities. The therapy was oriented to differentiated follicular
and papillary thyroid cancer (these topics are the leading ones
until today). The department covered the whole Czech Republic
and a part of the Slovak Republic. In 1985 the city hospital be-
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Figure 1. Clinic of Nuclear Medicine, 2nd Medical School, Charles
University Prague in new teachinc hospital, Prague Motol.
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Figure 2. Petr Vlcek, the
Head of Clinic.
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Diagnostics
The diagnostic department of the Clinic is equipped with 3
Sopha SPECT cameras and 1 planar camera. One of the SPECT
cameras is located in the therapeutic part and serves only for 131I
investigations. The department plays an important role in the dia-
gnostic complement of the hospital and there is tight co-opera-
tion with the departments of neurology, cardiology, oncology, etc.
The group also takes part in clinical studies (DatScan at present)
[4, 5]. About 6,000 patients are investigated per year.
The department is a reference place for Sopha in the Czech
Republic, which means that the members of the department are
teachers of the Sopha acquisition and processing software and
users from other departments are coming for excursions. In co-
operation with G&G Medical the camera consoles network was
connected to a PC with Interview. This connection enables export
of studies in Interfile data format to the PC for processing and
archiving and saves the machine time of the consoles.
Research and teaching
Research plays an important role at the Clinic. Next to the
already mentioned activities, there is strong co-operation in
projects for optimisation of complex treatment in children’s onco-
logy or predictive molecular diagnostics of families with medullary
thyroid cancer. In co-operation with the Institute of Information
Theory and Automation of the Czech Academy of Sciences the
mathematical methods for 131I therapy optimisation are being de-
veloped and together with the Computer Graphics Group at the
Faculty of Mathematics and Physics visualisation software for
SPECT and planar studies is being developed [6, 7]. In the field of
radiation protection, the Czech regulations are co-developed with
the State Office for Nuclear Safety and a Radiation Protection and
a Safety Centre is being established as a project of the IAEA.
As a part of the Faculty Hospital, the Clinic ensures lectures in
the topics of nuclear medicine and endocrinology for medical stu-
ô
ô
ô
ô
ô
ô
ô
ô
dents, postgraduate students and in continuing medical educa-
tion. The Clinic also accepts foreign guests and participates in
the IAEA education programme.
Co-operation
The Clinic consists of two main parts, therapy and diagnosis,
and also a physicist group. Diversity on the one hand, and perfect
co-operation inside the Clinic and outside towards other depart-
ments and hospitals on the other hand, creates the conditions for
multidisciplinary research and education. Active participation in and
many contributions at national and international conferences are
the proof of this. The openness for co-operation with other institu-
tions [8] and departments and the high standard of the department
help to fulfil the vision: to be and to be perceived as the leading
department in the field of nuclear imaging methods and therapy.
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